← Back to Search

Cough Control Therapy for Cough

N/A
Recruiting
Research Sponsored by West Park Healthcare Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, average 1 year
Awards & highlights

Study Summary

This trial will explore whether a non-pharmacological cough control therapy can help reduce the severity and impact of coughing on patients' lives who have ILD and chronic cough.

Who is the study for?
This trial is for individuals with any type of Interstitial Lung Disease (ILD) who have been coughing for more than 8 weeks. They must not have had changes in medication, respiratory exacerbations, or upper respiratory infections in the past month and should be able to perform exercise training.Check my eligibility
What is being tested?
The study tests a non-drug cough control therapy as an addition to pulmonary rehabilitation for ILD patients with chronic cough. It aims to see if this therapy can reduce the severity and impact of cough without using medications.See study design
What are the potential side effects?
Since the intervention is non-pharmacological, it's expected to have minimal side effects compared to drug treatments. However, specific side effects are not detailed as they may vary depending on individual patient responses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, average 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, average 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of intervention
Secondary outcome measures
Cough Hypersensitivity Questionnaire (CHQ)
Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT-F)
Global rating of change questionnaire (GRCQ)
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Non-pharmacological Cough control therapyExperimental Treatment1 Intervention
Participants will attend four virtual sessions of 45 to 60 minutes of educational and self-management. Sessions will be designed to target participants' needs and expectations according to the semi-structured theme. Session 1 General assessment Prescription of cough technique Session 2 Cough principles of cough Cough control Session 3 Breathing pattern retraining and laryngeal hygiene Session 4 Reinforcement of cough control therapies

Find a Location

Who is running the clinical trial?

West Park Healthcare CentreLead Sponsor
31 Previous Clinical Trials
2,222 Total Patients Enrolled
1 Trials studying Pulmonary Fibrosis
50 Patients Enrolled for Pulmonary Fibrosis
St. Joseph's Healthcare HamiltonOTHER
197 Previous Clinical Trials
26,424 Total Patients Enrolled
1 Trials studying Pulmonary Fibrosis
60 Patients Enrolled for Pulmonary Fibrosis

Media Library

Non-pharmacological Cough control Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04767074 — N/A
Pulmonary Fibrosis Research Study Groups: Non-pharmacological Cough control therapy
Pulmonary Fibrosis Clinical Trial 2023: Non-pharmacological Cough control Therapy Highlights & Side Effects. Trial Name: NCT04767074 — N/A
Non-pharmacological Cough control Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04767074 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
ThoraxJournal
Physiotherapy, and Speech and Language Therapy Intervention for Patients with Refractory Chronic Cough: A Multicentre Randomised Control Trial
Chamberlain Mitchell, Sarah A F, Rachel Garrod, Lynne Clark, Abdel Douiri, Sean M Parker, Jenny Ellis, Stephen J Fowler, et al.. 2016. “Physiotherapy, and Speech and Language Therapy Intervention for Patients with Refractory Chronic Cough: A Multicentre Randomised Control Trial”. Thorax. BMJ. doi:10.1136/thoraxjnl-2016-208843.
clinicaltrials.govStudy
A Non-pharmacological Cough Control Therapy
Dina Brooks 2020. "A Non-pharmacological Cough Control Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04767074.
All > Lung Disease > Pulmonary Fibrosis
~3 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top